Health Condition 1: L811- Chloasma
Conditions
Interventions
Intervention1: Kalaf Cream: It is planned to develop a Cream Form of Tila-e-Kalaf by converting it into a semisolid cream with anticipation to improve its efficacy, safety, and better patients’ compli
Sponsors
Jamia Hamdard (Deemed to be university)
Eligibility
Inclusion criteria
Inclusion criteria: Patients of all genders, belonging to 18 to 60 years of age and willing to participate in the trial voluntarily. Clinically diagnosed patients of epidermal melasma using Wood’s lamp (340-400 nm). Patients willing to sign the informed consent form.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. Female patient using oral contraceptives. Patients having field work jobs. Patients with drug or alcohol addiction. Patients with uncontrolled diabetes mellitus, renal disorders, severe liver, and heart diseases. Patients have used bleaching creams or topical steroid creams such as Azeliac acid, tretinoin and hydroquinone in the past 4 weeks before entering in the study. Patients who have undergone any laser therapies and chemical peeling or consuming photosensitizing substances in past 4 weeks. Patients having thyroid disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in MASI Scale Reduction in Melasma QoL Index Reduction in PGATimepoint: 1st,14th,28th,42nd,56th | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Yasmeen Shamsi
Jamia Hamdard
Outcome results
None listed